Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Galten/Låsby Autoriserede Fysioterapeuter og Træning ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.0% 1.8% 1.2% 1.8% 3.1% 1.6% 6.9% 6.9%   Credit score (0-100)   70 73 82 70 56 73 35 35   Credit rating   A A A A BBB A BBB BBB   Credit limit (kDKK)   0.2 1.9 83.3 1.5 0.0 6.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,731 3,811 4,105 3,811 3,817 4,830 0.0 0.0   EBITDA   447 418 1,162 418 73.4 1,116 0.0 0.0   EBIT   244 186 926 186 -156 889 0.0 0.0   Pre-tax profit (PTP)   130.9 138.1 847.0 138.1 -241.2 801.4 0.0 0.0   Net earnings   98.2 106.0 660.1 106.0 -190.8 624.1 0.0 0.0   Pre-tax profit without non-rec. items   131 138 847 138 -241 801 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   554 394 485 394 306 219 0.0 0.0   Shareholders equity total   944 2,068 1,962 2,068 1,877 2,501 2,451 2,451   Interest-bearing liabilities   891 529 362 529 678 12.8 0.0 0.0   Balance sheet total (assets)   3,581 4,832 5,077 4,832 4,742 5,198 2,451 2,451   Net Debt   653 495 59.9 495 661 -593 -904 -904     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,731 3,811 4,105 3,811 3,817 4,830 0.0 0.0   Gross profit growth   -8.9% 39.6% 7.7% -7.2% 0.2% 26.5% -100.0% 0.0%   Employees   10 8 9 8 7 9 0 0   Employee growth %   0.0% -20.0% 12.5% -11.1% -12.5% 28.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,581 4,832 5,077 4,832 4,742 5,198 2,451 2,451   Balance sheet change%   -18.5% 34.9% 5.1% -4.8% -1.9% 9.6% -52.8% 0.0%   Added value   446.8 417.9 1,161.6 417.9 75.7 1,115.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -196 -813 -4 -463 -458 -454 -219 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.9% 4.9% 22.6% 4.9% -4.1% 18.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.0% 5.7% 19.1% 4.9% -1.8% 19.4% 0.0% 0.0%   ROI %   9.8% 8.9% 32.4% 8.3% -2.9% 33.0% 0.0% 0.0%   ROE %   7.3% 7.0% 32.8% 5.3% -9.7% 28.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   26.4% 42.8% 38.6% 42.8% 39.6% 48.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   146.1% 118.5% 5.2% 118.5% 900.4% -53.2% 0.0% 0.0%   Gearing %   94.4% 25.6% 18.5% 25.6% 36.1% 0.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   15.5% 14.6% 22.6% 23.2% 25.6% 46.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 1.1 0.9 1.1 1.1 1.4 0.0 0.0   Current Ratio   0.3 1.1 1.0 1.1 1.1 1.4 0.0 0.0   Cash and cash equivalent   238.0 33.9 302.4 33.9 17.2 606.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,480.5 226.3 -101.1 226.3 214.3 946.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   45 52 129 52 11 124 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   45 52 129 52 10 124 0 0   EBIT / employee   24 23 103 23 -22 99 0 0   Net earnings / employee   10 13 73 13 -27 69 0 0